A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response-Reference-Cited by-同舟云学术

A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response

Published:2011-03 Issue:3 Volume:127 Page:654-660
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Varshney Pooja,Jones Stacie M.,Scurlock Amy M.,Perry Tamara T.,Kemper Alex,Steele Pamela,Hiegel Anne,Kamilaris Janet,Carlisle Suzanne,Yue Xiaohong,Kulis Mike,Pons Laurent,Vickery Brian,Burks A. Wesley

Funder

Henry Beresford, Duke University School of Nursing

Duke Clinical Research Unit

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Food allergy among U.S. children: trends in prevalence and hospitalizations;Branum;NCHS Data Brief,2008

2. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study;Sicherer;J Allergy Clin Immunol,2003

3. Fatalities due to anaphylactic reactions to foods;Bock;J Allergy Clin Immunol,2001

4. Further fatalities caused by anaphylactic reactions to food, 2001-2006;Bock;J Allergy Clin Immunol,2007

5. The natural history of peanut and tree nut allergy;Fleischer;Curr Allergy Asthma Rep,2007

Cited by 466 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose oral immunotherapy in immunoglobulin E-mediated food allergies;Frontiers in Immunology;2024-02-01

2. Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force;Allergy;2024-01-23

3. Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy;Medicina;2024-01-09

4. Exploratory immunogenicity outcomes of peanut oral immunotherapy: Findings from the PALISADE trial;Clinical and Translational Allergy;2024-01

5. Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial;Journal of Allergy and Clinical Immunology;2024-01